Stereotaxis Announces Grand Opening of New Global Headquarters in St. Louis
March 09 2022 - 8:06AM
Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical
robotics for minimally invasive endovascular intervention, today is
holding the grand opening of its new, 45,000-square-foot global
headquarters facility in downtown St. Louis.
Located in the renovated historic Globe Building
in St. Louis’s growing Downtown North Urban Insight District, the
new global corporate headquarters is an all-in-one facility
offering high-tech research and development, advanced
manufacturing, and distribution space for the company’s pipeline of
cutting-edge robotic surgery technologies. Stereotaxis, which
employs over 130 professionals in ten countries globally, designed
its headquarters to accommodate significant long-term growth.
The grand opening celebration and news
conference today is planned to include remarks and a tour of the
facilities, including hands-on demonstrations of the Robotic
Magnetic Navigation technology that has been used in over a hundred
hospitals globally to treat more than 100,000 patients.
Distinguished guests joining for the Grand Opening include:
Missouri Governor, Mike Parson; St. Louis Board of Alderman
President, Lewis Reed; Executive Director of the St. Louis
Development Corp., Neal Richardson; St. Louis Ward 5 Alderman,
James Page; Globe Building Managing Partner, Steve Stone; and
Co-Founder and Managing Partner of The Starwood Group, John
Berglund. The event will be emceed by CEO of Community Development
Ventures, Inc., Dick Fleming. David Fischel and Governor Parson
will demonstrate Stereotaxis’ robotic surgical technology in one of
the headquarters’ interventional operating rooms in which doctors
are trained on the equipment.
“Stereotaxis is delighted to inaugurate a modern
new headquarters that serves as a foundation for years of progress
and growth,” said Chairman and CEO, David Fischel. “We appreciate
the many community leaders who have supported a growing, high-tech
innovation ecosystem in St. Louis. We look forward to contributing
to the revitalization of downtown St. Louis and pioneering
innovations that improve endovascular surgery.”
About StereotaxisStereotaxis
(NYSE: STXS) is a pioneer and global leader in innovative surgical
robotics for minimally invasive endovascular intervention. Its
mission is the discovery, development and delivery of robotic
systems, instruments, and information solutions for the
interventional laboratory. These innovations help physicians
provide unsurpassed patient care with robotic precision and safety,
expand access to minimally invasive therapy, and enhance the
productivity, connectivity, and intelligence in the operating room.
Stereotaxis technology has been used to treat over 100,000 patients
across the United States, Europe, Asia, and elsewhere. For more
information, please visit www.stereotaxis.com.
This press release includes statements that may
constitute "forward-looking" statements, usually containing the
words "believe”, "estimate”, "project”, "expect" or similar
expressions. Forward-looking statements inherently involve risks
and uncertainties that could cause actual results to differ
materially. Factors that would cause or contribute to such
differences include, but are not limited to, the Company's ability
to manage expenses at sustainable levels, acceptance of the
Company's products in the marketplace, the effect of global
economic conditions on the ability and willingness of customers to
purchase its technology, competitive factors, changes resulting
from healthcare policy, dependence upon third-party vendors, timing
of regulatory approvals, the impact of pandemics or other
disasters, and other risks discussed in the Company's periodic and
other filings with the Securities and Exchange Commission. By
making these forward-looking statements, the Company undertakes no
obligation to update these statements for revisions or changes
after the date of this release. There can be no assurance that the
Company will recognize revenue related to its purchase orders and
other commitments because some of these purchase orders and other
commitments are subject to contingencies that are outside of the
Company's control and may be revised, modified, delayed, or
canceled.
Stereotaxis Investor Contacts: |
Media
Contact: |
David L. Fischel |
Bethanne Schluter |
Chairman and Chief Executive Officer |
Stereotaxis Communications |
|
314-532-1255 |
Kimberly Peery |
bethanne.schluter@stereotaxis.com |
Chief Financial Officer |
|
|
|
314-678-6100 |
|
investors@stereotaxis.com |
|
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From Apr 2024 to May 2024
Stereotaxis (AMEX:STXS)
Historical Stock Chart
From May 2023 to May 2024